About this trial
Trigeminal neuralgia is a severe chronic pain condition with a major impact on quality of life. Although Gamma Knife radiosurgery is an established treatment for pharmacoresistant trigeminal neuralgia, its mechanisms of action and the temporal dynamics of clinical response remain incompletely understood.
This prospective longitudinal study aims to investigate changes in brain functional connectivity using resting-state functional magnetic resonance imaging (rs-fMRI) in patients with classical trigeminal neuralgia treated with Gamma Knife radiosurgery. Participants will undergo rs-fMRI examinations before treatment and at 1 month, 3 months, and 12 months after radiosurgery.
Functional connectivity patterns will be analyzed over time and correlated with clinical outcomes, including pain intensity and treatment response. Imaging data will be compared with those from a cohort of age- and sex-matched healthy volunteers. The study does not modify standard clinical care; only additional non-invasive MRI examinations without contrast injection are performed for research purposes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 to 73 years
Diagnosis of classical trigeminal neuralgia confirmed by an experienced neurologist
Unilateral facial pain with a normal neurological examination
Pharmacoresistant trigeminal neuralgia, defined as failure of at least two appropriate medical treatments, intolerance to medication, or recurrence despite adequate treatment
Disqualifiers
Diagnostic uncertainty or secondary/idiopathic trigeminal neuralgia
Previous surgical or radiosurgical treatment for trigeminal neuralgia
Participation in another interventional clinical study at the time of inclusion
Individuals belonging to protected populations as defined by applicable regulations (including minors, adults under legal protection, persons deprived of liberty, pregnant or breastfeeding women)
Trial design
Single group
Treatments tested in this trial
Resting-State Functional MRI
Procedure/SurgeryParticipants undergo non-invasive resting-state functional magnetic resonance imaging (rs-fMRI) examinations without contrast injection. Imaging sessions are performed before Gamma Knife radiosurgery and at 1 month, 3 months, and 12 months after treatment. These MRI procedures are conducted solely for research purposes and do not modify standard clinical care. The intervention aims to assess longitudinal changes in brain functional connectivity and their association with clinical outcomes.
Treatment groups
Trial outcomes
Primary outcomes
Normalization of resting-state functional connectivity at 3 months
Percentage of normalization of resting-state functional MRI (rs-fMRI) connectivity patterns at 3 months after Gamma Knife radiosurgery, compared with pre-treatment imaging and with age- and sex-matched healthy control data.
Secondary outcomes
Longitudinal changes in resting-state functional connectivity
Percentage of normalization of rs-fMRI connectivity patterns at 1 month, 3 months, and 12 months after Gamma Knife radiosurgery, compared with pre-treatment imaging.
Pain outcome assessed by Barrow Neurological Institute (BNI) Pain Intensity Scale
Change in pain status assessed using the Barrow Neurological Institute Pain Intensity Scale
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: